JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"

Form of Proxy for the Annual General Meeting

Form of Proxy for the Annual General Meeting

NOTICE OF THE ANNUAL GENERAL MEETING OF 2021

NOTICE OF THE ANNUAL GENERAL MEETING OF 2021

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2022

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2022

CONNECTED TRANSACTION BIORICHLAND LEASE (2022 RENEWAL) AGREEMENT

CONNECTED TRANSACTION BIORICHLAND LEASE (2022 RENEWAL) AGREEMENT

PROPOSED ADOPTION OF SHARE INCENTIVE SCHEME (H SHARES)

PROPOSED ADOPTION OF SHARE INCENTIVE SCHEME (H SHARES)

DISCLOSEABLE TRANSACTION - ACQUISITION OF YINMORE BIO-TECH

DISCLOSEABLE TRANSACTION - ACQUISITION OF YINMORE BIO-TECH

DISCLOSEABLE TRANSACTION - ACQUISITION OF WEIMEI BIO-TECH

DISCLOSEABLE TRANSACTION - ACQUISITION OF WEIMEI BIO-TECH

CHANGE OF JOINT COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE

CHANGE OF JOINT COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE

Leave us a message

Thank you for your attention to JOINN. Please fill in the information below, and we will contact you promptly.

Message

Message

top